Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 9 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 2 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 2, subfamily D, polypeptide 6 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | Cytochrome P450 family protein | Get druggable targets OG5_126582 | All targets in OG5_126582 |
Loa Loa (eye worm) | cytochrome P450 family protein | Get druggable targets OG5_126582 | All targets in OG5_126582 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | cytochrome P450 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 497 aa | 425 aa | 32.0 % |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 490 aa | 441 aa | 21.8 % |
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 2 | 516 aa | 470 aa | 26.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | ribonuclease H1, putative | 0.0025 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | ribonuclease HI | 0.0025 | 0 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0065 | 0.407 | 0.3431 |
Echinococcus multilocularis | tar DNA binding protein | 0.0065 | 0.407 | 1 |
Treponema pallidum | ribonuclease H (rnhA) | 0.0025 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.407 | 0.5618 |
Onchocerca volvulus | Ribonuclease H1 homolog | 0.0025 | 0 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0065 | 0.407 | 0.3431 |
Brugia malayi | RNA binding protein | 0.0065 | 0.407 | 0.407 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0051 | 0.2641 | 0.2641 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.407 | 0.5618 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.2641 | 0.1849 |
Schistosoma mansoni | hypothetical protein | 0.0095 | 0.7244 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0122 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.407 | 0.5618 |
Trypanosoma cruzi | ribonuclease H1, putative | 0.0025 | 0 | 0.5 |
Trypanosoma brucei | RNA helicase, putative | 0.0095 | 0.7244 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0036 | 0.1091 | 0.1091 |
Giardia lamblia | Ribonuclease H | 0.0025 | 0 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0122 | 1 | 1 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0028 | 0.0224 | 0.0309 |
Trypanosoma brucei | unspecified product | 0.0028 | 0.0224 | 0.0309 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0036 | 0.1091 | 0.0131 |
Toxoplasma gondii | ribonuclease HI protein | 0.0025 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.407 | 0.5618 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0051 | 0.2641 | 0.2641 |
Trichomonas vaginalis | ribonuclease H1, putative | 0.0025 | 0 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0065 | 0.407 | 0.407 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0028 | 0.0224 | 0.0309 |
Echinococcus granulosus | tar DNA binding protein | 0.0065 | 0.407 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0051 | 0.2641 | 0.1849 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0028 | 0.0224 | 0.0309 |
Loa Loa (eye worm) | RNA binding protein | 0.0065 | 0.407 | 0.3431 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0035 | 0.0972 | 0.0972 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.407 | 0.5618 |
Leishmania major | ribonuclease H1, putative | 0.0025 | 0 | 0.5 |
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.0028 | 0.0224 | 0.0309 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0972 | 0.1342 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0065 | 0.407 | 0.407 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | = 0.630957344 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 2.511886432 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 10 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
Potency (ADMET) | = 2.5119 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6. (Class of assay: confirmatory) [Related pubchem assays: 410 ] | ChEMBL. | No reference |
Potency (ADMET) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9. (Class of assay: confirmatory) [Related pubchem assays: 885, 884, 410 ] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.